Skip to main content

Table 4 Estimated p-values for compared treatment modalities for heart, LAD and contralateral breast

From: The choice of multi-beam IMRT for whole breast radiotherapy in early-stage right breast cancer

Metric

A versus B

A versus C

A versus D

A versus E

B versus C

B versus D

B versus E

C versus D

C versus E

D versus E

Heart (RB)

 Dmax

NS

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

NS

0.007

0.013

 Dmean

NS

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

0.002

NS

0.007

 V5 (%)

NS

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

NS

NS

NS

 V10 (%)

NS

<0.001

NS

0.030

<0.001

NS

0.030

NS

NS

NS

LAD (RB)

 Dmax

NS

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

NS

0.002

0.016

 Dmean

NS

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

0.022

0.026

NS

CB (RB)

 V3 (%)

NS

<0.001

<0.001

0.006

<0.001

<0.001

0.006

0.001

NS

<0.001

 V5 (%)

NS

NS

<0.001

NS

NS

<0.001

NS

0.003

NS

<0.001

  1. A, three-dimensional conformal radiotherapy (3DCRT); B, forward-planned intensity-modulated radiotherapy (for-IMRT); C, inverse-planned intensity-modulated radiotherapy (inv-IMRT); D, helical tomotherapy (HT) and E, volumetric-modulated arc therapy (VMAT); RB, right breast, CB, contralateral breast and NS, no significant statistical differences